Zscaler Trades Near 52-Week Low: Time to Hold the Stock or Exit?

Zscaler shares have fallen 32.4% since May 26 and are now just 8.8% above their 52-week low after management flagged fiscal 2027 revenue and ARR growth deceleration to 16%–17%, roughly 800–900 bps below prior mid-20s growth. Despite the weak guidance, Q3 revenue rose 25% to $850 million, ARR increased 25% to $3.53 billion, and RPO climbed about 30% to $6.5 billion, indicating underlying demand remains healthy. The article argues the selloff may be overdone given AI security momentum, expanding platform adoption, and a forward P/S multiple of 5.27 versus the industry’s 14.75.

Analysis

The market is pricing ZS as if the business has entered a structural slowdown, but the more important read-through is that the selloff is creating a one-quarter narrative reset, not a demand break. When a software name with strong gross retention and expanding multi-product penetration rerates this hard on guidance, it usually reflects fear that management has lost visibility, which can persist for 1-2 reporting cycles even if the underlying bookings trend stays intact. That sets up an asymmetric setup: near-term multiple compression can continue, but the downside from here is increasingly about execution slippage rather than business model impairment.

The second-order issue is competitive positioning inside zero trust and data security. If ZS is forced to be more conservative on new-logo assumptions, the likely winners are the vendors with broader platform adjacency and larger CIO wallet share, not necessarily the fastest-growing point solutions. That favors PANW on enterprise consolidation and CRWD on endpoint-to-cloud cross-sell, while FTNT benefits if buyers continue preferring integrated networking/security budgets over best-of-breed expansion. The real risk for ZS is that sales leadership turnover interrupts pipeline conversion precisely when macro buyers are already more selective.

Contrarianly, the market may be underappreciating how much optionality AI security contributes to the long-duration story. The near-term bookings contribution is still early, but AI workload protection can change budget category size rather than simply reallocate spend within cybersecurity. If that thesis compounds, the current valuation discount could prove temporary; however, it likely needs another 2-3 quarters of clean execution before investors will pay for it. In the meantime, the stock is likely to trade as a credibility story, not a fundamentals story.

Key Decisions for Investors

• Maintain a tactical short-term underweight ZS for the next 1-2 quarters; the stock can stay cheap while the Street recalibrates FY27, but cover aggressively if management stabilizes sales leadership and beats bookings in the next print.
• Prefer long PANW over ZS on a 3-6 month basis as a consolidation beneficiary; the risk/reward is better because platform breadth should attract budget share if buyers are tightening vendor counts.
• Use the drawdown to initiate a small starter long ZS only on confirmation of demand inflection; best entry is after the next earnings print if ARR and RPO re-accelerate, with upside from multiple expansion back toward peer discounts closing.
• Pair trade: long CRWD / short ZS for 1-2 quarters; if security budgets remain intact, the market should reward the vendor with cleaner execution and broader AI/security narrative while continuing to punish execution uncertainty at ZS.
• Sell downside puts rather than buy stock outright if seeking exposure to a rebound; the implied move likely embeds too much panic, but the fundamental catalyst path remains back-half weighted.